Skip to Content
Merck
CN

P4308

Potassium hexahydroxoantimonate(V)

powder

Synonym(s):

Potassium antimonate, hydrated

Sign In to View Organizational & Contract Pricing.

Select a Size

About This Item

Linear Formula:
KSb(OH)6
CAS Number:
12208-13-8
Molecular Weight:
262.90
NACRES:
NA.23
PubChem Substance ID:
57654525
UNSPSC Code:
12352302
EC Number:
235-387-7
MDL number:
MFCD00011415
Form:
powder

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Product Name

Potassium hexahydroxoantimonate(V),

InChI key

DUBGVNNAYGFUKU-UHFFFAOYSA-H

InChI

1S/K.6H2O.Sb/h;6*1H2;/q+1;;;;;;;+5/p-6

SMILES string

[K+].O[Sb-](O)(O)(O)(O)O

form

powder

reaction suitability

core: potassium

concentration

44.3-49.8% Sb (iodometric)

Quality Level

200

Looking for similar products? Visit Product Comparison Guide

Related Categories

Application

Potassium hexahydroxoantimonate(V) can be used as a precursor salt to synthesize:
  • Antimony oxide (Sb2O3), which is applicable as a sorbent material for the removal of cobalt from radioactive waste.
  • Amphiphilic antimony(V)complexes.

pictograms

Exclamation markEnvironment
GHS07,GHS09

signalword

Warning

Hazard Classifications

Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 2

Storage Class

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

wgk

WGK 2

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

dust mask type N95 (US), Eyeshields, Gloves

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
BCCN6797
BCCN5850
BCCN0244
BCCL9649
BCCJ0063

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Flaviana R Fernandes et al.
Antimicrobial agents and chemotherapy, 57(9), 4229-4236 (2013-06-26)
The need for daily parenteral administration is an important limitation in the clinical use of pentavalent antimonial drugs against leishmaniasis. In this study, amphiphilic antimony(V) complexes were prepared from alkylmethylglucamides (L8 and L10, with carbon chain lengths of 8 and

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service